| Iupac Name: | 4-cyano-2-dimethylamino-4,4-diphenylbutane |
| Width: | 160 |
| Legal Br: | A1 |
| Legal Br Comment: | [1] |
| Legal Un: | N I |
| Legal De: | Anlage II |
| Routes Of Administration: | N/A |
| Cas Number: | 125-79-1 |
| Unii: | 0GYB2HJA89 |
| Atc Prefix: | none |
| Pubchem: | 31331 |
| Kegg: | C22686 |
| Chemspiderid: | 29065 |
| C: | 19 |
| H: | 22 |
| N: | 2 |
| Smiles: | CC(CC(C#N)(C1=CC=CC=C1)C2=CC=CC=C2)N(C)C |
| Stdinchi: | 1S/C19H22N2/c1-16(21(2)3)14-19(15-20,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-13,16H,14H2,1-3H3 |
| Stdinchikey: | GJJQIGFCGLPOQK-UHFFFAOYSA-N |
Methadone intermediate (Pre-methadone, Methadone nitrile, Dimethylaminodiphenylbutanonitrile) is a methadone precursor scheduled by UN Single Convention on Narcotic Drugs. It is a Schedule II Narcotic controlled substance in the United States and has an ACSCN of 9254. The 2014 annual manufacturing quota was 32 875 kilos.[2] It is listed as a Schedule I drug in Canada,[3] but is only significant as a precursor for methadone, as it does not have analgesic activity in its own right, though it does show some atropine-like activity.[4]